Decision Content

This document is an unofficial consolidation of all amendments to Multilateral Instrument 51-105 Issuers Quoted in the U.S. Over-the-Counter Markets, effective as of June 9, 2023. This document is for reference purposes only. The unofficial consolidation of the Instrument is not an official statement of the law.

 

 

 

MULTILATERAL INSTRUMENT 51-105

ISSUERS QUOTED IN THE U.S. OVER-THE-COUNTER MARKETS

 

TABLE OF CONTENTS

 

PART 1 – DEFINITIONS AND REPORTING ISSUER DESIGNATION AND DETERMINATION

1.       Definitions

2.       National Instrument definitions apply

3.       Reporting issuer designation and determination

4.       Ceasing to be an OTC reporting issuer

 

PART 2 – DISCLOSURE

5.       Additional disclosure requirements

6.       Timely disclosure obligations

7.       Registration statement

8.       Promotional activities

9.       Technical reportsmineral properties

10.   Personal information form and authorization

 

PART 3 – RESALE OF PRIVATE PLACEMENT SECURITIES

11.   Resale of seed stock

12.   Legends on seed stock

13.   Resale of private placement securities acquired after ticker-symbol date

14.   No other hold periods

 

PART 4 – OTHER RESTRICTIONS

15.   Securities for services

16.   Take-over bid

17.   Insider reports

 

PART 5 – EXEMPTION

18.   Exemption

 

PART 6 – TRANSITION AND COMING INTO FORCE

19.   Transition financial disclosure for non-SEC filers

20.   Transition oil and gas disclosure

21.   Coming into force

 

                   

 


MULTILATERAL INSTRUMENT 51-105

ISSUERS QUOTED IN THE U.S. OVER-THE-COUNTER MARKETS

 

 

PART 1 – DEFINITIONS AND REPORTING ISSUER DESIGNATION AND DETERMINATION

Definitions

1.                     In this Instrument:

 

"OTC issuer" means an issuer

 

(a)    that has issued a class of securities that are OTC-quoted securities, and

 

(b)    that has not issued any class of securities that are listed or quoted on one or more of the following:

 

(i)           TSX Venture Exchange Inc.;

 

(ii)         TSX Inc.;

 

(iii)       Canadian National Stock Exchange;

 

(iv)        Alpha Exchange Inc.;

 

(v)          The New York Stock Exchange LLC;

 

(vi)        NYSE Amex LLC;

 

(vii)      The NASDAQ Stock Market LLC;

 

(viii)    Aequitas NEO Exchange Inc.;

 

"OTC-quoted securities" means a class of securities that has been assigned a ticker symbol by the Financial Industry Regulatory Authority in the United States of America for use on any of the over-the-counter markets in the United States of America and includes a class of securities whose trades have been reported in the grey market;

 

"OTC reporting issuer" means an OTC issuer that is a reporting issuer;

 

"promotional activities" means activities or communications, by or on behalf of an issuer, that promote or could reasonably be expected to promote the purchase or sale of securities of the issuer, but does not include any of the following:

 

(a) the dissemination of information or preparation of records in the ordinary course of the business of the issuer

 

(i) to promote the sale of products or services of the issuer, or

 

(ii) to raise public awareness of the issuer;

 

(b) activities or communications necessary to comply with the requirements of

 

(i) the securities legislation of any jurisdiction of Canada;


(ii) the securities laws of any foreign jurisdiction governing the issuer;

 

(iii) any exchange or market on which the issuer’s securities trade;

 

"ticker-symbol date" means the date that an OTC issuer is first assigned a ticker symbol for any class of its securities;

 

"trade", in Québec, for the purpose of this Instrument, refers to any of the following activities:

 

(a) the activities described in the definition of "dealer" in section 5 of the Securities Act (R.S.Q., c. V-1.1), including the following activities:

 

(i) the sale or disposition of a security by onerous title, whether the terms of payment be on margin, instalment or otherwise, but does not include a transfer or the giving in guarantee of securities in connection with a debt or the purchase of a security, except as provided in paragraph (b);

 

(ii) participation as a trader in any transaction in a security through the facilities of an exchange or a quotation and trade reporting system;

 

(iii) the receipt by a registrant of an order to buy or sell a security;

 

(b) a transfer or the giving in guarantee of securities of an issuer from the holdings of a control person in connection with a debt.

 

National Instrument definitions apply

2.                     Terms used in this Instrument that are defined or interpreted in National Instrument 51-102 Continuous Disclosure Obligations have the same meaning in this Instrument.

 

Reporting issuer designation and determination

3.                     An OTC issuer is a reporting issuer under securities legislation if one or more of the following apply:

 

(a) on or after July 31, 2012, its business has been directed or administered in or from the local jurisdiction;

 

(b) on or after July 31, 2012, promotional activities have been carried on in or from the local jurisdiction;

 

(c) the ticker-symbol date is on or after July 31, 2012, and, on or before the ticker-symbol date, the issuer distributed a security to a person resident in the local jurisdiction and that security is of the class of securities that became the issuer’s OTC-quoted securities.

 

Ceasing to be an OTC reporting issuer

4(1)                  Except in Québec, an OTC issuer ceases to be a reporting issuer under section 3 if all of the following conditions are met:

 

(a) its business is not directed or administered, and has not been directed or administered for at least one year, in or from the local jurisdiction;

 

(b) promotional activities are not carried on, and have not been carried on for at least one year, in or from the local jurisdiction;

 

(c) more than one year has passed since the ticker-symbol date;

 

(d) it has filed Form 51-105F1 Notice OTC Issuer Ceases to be an OTC Reporting Issuer.

4.(2)                 Except in Québec, if an OTC reporting issuer ceases to be an OTC issuer as a result of its securities being listed or quoted on an exchange or a quotation and trade reporting system specified in the definition of "OTC issuer" in section 1, the OTC reporting issuer must file Form 51-105F4 Notice Issuer Ceases to be an OTC Reporting Issuer at least 10 days before its next required filing under securities legislation in the local jurisdiction.

 

4.(3)                 In Québec, an OTC reporting issuer must apply to the securities regulatory authority to have its status as an OTC reporting issuer revoked in order to cease to be a reporting issuer under section 3.

 

 

PART 2 – DISCLOSURE

 

 

Additional disclosure requirements

5.                     In addition to all other provisions of securities legislation that apply to a reporting issuer and its insiders, an OTC reporting issuer must comply with the provisions of the following National Instruments:

 

(a) National Instrument 13-103 System for Electronic Data Analysis and Retrieval + (SEDAR+);

 

(b) National Instrument 51-102 Continuous Disclosure Obligations that apply to a reporting issuer that is a venture issuer;

 

(c) Part 6 of National Instrument 51-102 Continuous Disclosure Obligations despite section 6.1 of that Instrument;

 

(d) National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings that apply to a reporting issuer that is a venture issuer;

 

(e) National Instrument 52-110 Audit Committees that apply to a reporting issuer that is a venture issuer;

 

(f) National Instrument 58-101 Disclosure of Corporate Governance Practices that apply to a reporting issuer that is a venture issuer.

 

Timely disclosure obligations

6.(1)                 Section 14.2 of National Instrument 71-101 The Multijurisdictional Disclosure System and section 4.2 of National Instrument 71-102 Continuous Disclosure and Other Exemptions Relating to Foreign Issuers do not apply to an OTC reporting issuer.

 

6.(2)                 An OTC reporting issuer may file a copy of the Form 8-K Current Report that it files with the SEC to comply with its obligation in paragraph 7.1 (1) (b) of National Instrument 51-102 Continuous Disclosure Obligations to file Form 51-102F3 Material Change Report.

 

Registration statement

7.(1)                 If an OTC issuer becomes a reporting issuer on the ticker-symbol date, the OTC reporting issuer must file, within 5 days of the date it became a reporting issuer, a copy of the most recent registration statement it filed with the SEC.

 

7.(2)                 The OTC reporting issuer must file the registration statement in electronic format under section 2.2 of National Instrument 13-103 System for Electronic Data Analysis and Retrieval + (SEDAR+).

 

Promotional activities

8.(1)                 If a person will carry on promotional activities under an agreement, arrangement, commitment or understanding with an OTC reporting issuer, the OTC reporting issuer must file a notice in the form of Form 51-105F2 Notice of Promotional Activities naming the person and describing the activities and the relationship of the OTC reporting issuer with the person, and the particulars of their agreement, arrangement, commitment or understanding with the OTC reporting issuer.

 

8.(2)                 The OTC reporting issuer must file the notice under subsection (1) within one of the following dates:

 

(a) at least one day before the promotional activities commence;

 

(b) if, on the date the OTC issuer became an OTC reporting issuer, promotional activities are being carried on, within 5 days of that date.

 

8(3)                  The OTC reporting issuer must file the notice in electronic format in accordance with National Instrument 13-103 System for Electronic Data Analysis and Retrieval + (SEDAR+).

 

Technical reports mineral properties

9.                     Section 4.1 of National Instrument 43-101 Standards of Disclosure for Mineral Projects does not apply to an OTC reporting issuer.

 

Personal information form and authorization

10.(1)               Each director, officer, promoter and control person of an OTC reporting issuer must deliver to the securities regulatory authorities Form 51-105F3A Personal Information Form and Authorization of Indirect Collection, Use and Disclosure of Personal Information or Form 51-105F3B Personal Information Form and Authorization of Indirect Collection, Use and Disclosure of Personal Information within 10 days of the issuer becoming an OTC reporting issuer, except for a promoter of an OTC issuer that becomes an OTC reporting issuer more than 2 years after the ticker-symbol date.

 

10.1(2)              Each person that becomes a director, officer, promoter or control person of an OTC reporting issuer must deliver to the securities regulatory authorities a personal information form referred to in subsection (1) within 10 days of becoming a director, officer, promoter or control person of an OTC reporting issuer.

 

10.1(3)              If a promoter or control person is not an individual, then each of its directors, officers and control persons must deliver a personal information form referred to in subsection (1) to the securities regulatory authorities within 10 days of the promoter or control person becoming a promoter or control person of an OTC reporting issuer.

 

 

PART 3 – RESALE OF PRIVATE PLACEMENT SECURITIES

 

 

Resale of seed stock

11.                    After the ticker-symbol date, a person must not trade a security of an OTC reporting issuer that the person acquired on or after July 31, 2012, and before the ticker-symbol date unless either of the following occurs:

 

(a) the trade is in connection with one or more of the following:

 

(i) a take-over bid or an issuer bid in a jurisdiction of Canada;

(ii) an amalgamation, merger, reorganization or arrangement that is under a statutory procedure or court order;

 

(iii) a dissolution or winding-up of the issuer that is under a statutory procedure or court order;

 

(b) all of the following conditions are met:

 

(i) the certificate representing the security carries the legend, or the ownership statement issued under a direct registration system or other electronic book entry system relating to the security bears the legend restriction notation, set out in subsection 12 (2);

 

(ii) the person trades the security through an investment dealer registered in a jurisdiction of Canada from an account at that investment dealer in the name of that person;

 

(iii) the investment dealer executes the trade through any of the over-the-counter markets in the United States of America.

 

Legends on seed stock

12.(1)               As soon as practicable after the ticker-symbol date, an OTC reporting issuer must place

 

(a) a legend on each certificate representing a security issued before the ticker-symbol date, and

 

(b) a legend restriction notation on each ownership statement issued under a direct registration system or other electronic book entry system relating to a security issued before the ticker-symbol date.

 

12.(2)               The legend and legend restriction notation must state the following

 

Unless permitted under section 11 of Multilateral Instrument 51-105 Issuers Quoted in the U.S. Over-the-Counter Markets, the holder of this security must not trade the security in or from a jurisdiction of Canada unless

 

(a) the security holder trades the security through an investment dealer registered in a jurisdiction of Canada from an account at that dealer in the name of that security holder, and

 

(b) the dealer executes the trade through any of the over-the-counter markets in the United States of America.

 

Resale of private placement securities acquired after ticker-symbol date

13.(1)               A person must not trade a security of an OTC reporting issuer that the person acquired under an exemption from the prospectus requirement after the ticker-symbol date unless the following conditions are satisfied:

 

(a) unless the security was acquired under a director or employee stock option, a 4-month period has passed from one of the following:

 

(i) the date the OTC reporting issuer distributed the security;

 

(ii) the date a control person distributed the security;

 

(b) if the person trading the security is a control person of the OTC reporting issuer, the person has held the security for at least 6 months;

 

(c) the number of securities the person proposes to trade, plus the number of securities of the OTC reporting issuer of the same class that the person has traded in the preceding 12-month period, does not exceed 5% of the OTC reporting issuer’s outstanding securities of the same class;

 

(d) the person trades the security through an investment dealer registered in a jurisdiction of Canada;

 

(e) the investment dealer executes the trade through any of the over-the-counter markets in the United States of America;

 

(f) there has been no unusual effort made to prepare the market or create a demand for the security;

 

(g) no extraordinary commission or other consideration is paid to a person for the trade;

 

(h) if the person trading the security is an insider of the OTC reporting issuer, the person reasonably believes that the OTC reporting issuer is not in default of securities legislation;

 

(i) the certificate representing the security bears a legend, or the ownership statement issued under a direct registration system or other electronic book entry system relating to the security bears a legend restriction notation, stating the following:

 

The holder of this security must not trade the security in or from a jurisdiction of Canada unless the conditions in section 13 of Multilateral Instrument 51- 105 Issuers Quoted in the U.S. Over-the-Counter Markets are met.

 

13.(2)               Despite subsection (1), a person may trade a security of an OTC reporting issuer that the person acquired under an exemption from the prospectus requirement if the trade is in connection with one or more of the following:

 

(a) a take-over bid or an issuer bid in a jurisdiction of Canada;

 

(b) an amalgamation, merger, reorganization or arrangement that is under a statutory procedure or court order;

 

(c) a dissolution or winding-up of the issuer that is under a statutory procedure or court order.

 

No other hold periods

14.                    Sections 2.3, 2.4, 2.5 and 2.6 of National Instrument 45-102 Resale of Securities do not apply to the first trade of a security of an OTC reporting issuer distributed under an exemption from the prospectus requirement.

 

 

PART 4 – OTHER RESTRICTIONS

 

 

Securities for services

15.                    An OTC reporting issuer must not distribute a security to a director, officer, or consultant of the issuer for the provision of a service unless

 

(a) the consideration for the service is commercially reasonable,

 

(b) in the case of a debt, the debt is a bona fide debt, and

 

(c) the security is distributed for a price that is at least at its current market value.

Take-over bid

16.                    Section 4.2 of National Instrument 62-104 Take-Over Bids and Issuer Bids does not apply to a take-over bid for an OTC reporting issuer for 2 years after the ticker-symbol date.

 

Insider reports

17.                    A person that is exempt or otherwise not required to file an insider report under U.S. federal securities law relating to insider reporting may not rely on the exemption from insider reporting under section 17.1 of National Instrument 71-101 The Multijurisdictional Disclosure System or section 4.12 of National Instrument 71-102 Continuous Disclosure and Other Exemptions Relating to Foreign Issuers.

 

 

PART 5 – EXEMPTION

 

 

Exemption

18.                    The regulator, except in Québec, or securities regulatory authority may, under the statute referred to in Appendix B of National Instrument 14-101 Definitions opposite the name of the local jurisdiction, grant an exemption from this Instrument.

 

 

PART 6 – TRANSITION AND COMING INTO FORCE

 

 

Transition financial disclosure for non-SEC filers

19.                    Except in British Columbia, for an OTC reporting issuer that does not have a class of securities registered under section 12 of the 1934 Act and is not required to file reports under paragraph 15 (d) of the 1934 Act, the requirements of National Instrument 51-102 Continuous Disclosure Obligations and National Instrument 52-109 Certification of Disclosure in Issuers’ Annual and Interim Filings concerning the filing of

 

(a) annual financial statements, related MD&A and annual certificates apply only to financial years beginning on or after January 1, 2012,

 

(b) interim financial reports, related MD&A and interim certificates apply only to interim periods that

 

(i) begin on or after January 1, 2012, and

 

(ii) end after July 31, 2012, and

 

(c) AIFs apply only to financial years beginning on or after January 1, 2012.

 

Transition oil and gas disclosure

20.                    Except in British Columbia, for an OTC reporting issuer, the requirement of National Instrument 51-101 Standards of Disclosure for Oil and Gas Activities concerning the filing of Form 51-101F1 Statement of Reserves Data and Other Oil and Gas Information applies only to financial years beginning on or after January 1, 2012.

 

Coming into force

21.(1)               This Instrument comes into force on July 31, 2012.

 

21.(2)               Despite subsection (1), except in British Columbia, sections 5, 6, 7, and 8 come into force on September 30, 2012.

 You are being directed to the most recent version of the statute which may not be the version considered at the time of the judgment.